Biocon Limited, together with its subsidiaries, engages in the manufacture and sale of biotechnology products and research services in India, Brazil, Singapore, and internationally. It operates through four segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company offers generic formulations and API products, including anti-diabetics, immunosuppressants, multiple sclerosis, anti-cancer/oncology, and other products; novel biologics products, such as head and neck cancer molecule; novel pipeline products comprising psoriasis molecules; and biosimilars products consisting of insulins, trastuzumab, pegfilgrastim, and bevacizumab. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer good, and agrochemical companies. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
तुलना करने के लिए मीट्रिक्स | BION | पीअर्स समकक्ष - बारीकी से मेल खाने वाली कंपनियों से संबंधित मेट्रिक्स का औसत BION: PANACEABIO, 688177, VRTX, ZYDUSLIFE, BIIB | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधBIONपीअर्सक्षेत्र |
---|---|---|---|---|
पी/ई अनुपात | 26.3x | 25.6x | −0.6x | |
PEG अनुपात | 0.10 | 0.31 | 0.00 | |
क़ीमत/बुक | 2.1x | 5.4x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.8x | 5.0x | 3.3x | |
अपसाइड (विश्लेषक लक्ष्य) | −4.1% | 5.7% | 49.0% | |
उचित मूल्य अपसाइड | अनलॉक करें | −17.4% | 7.7% | अनलॉक करें |